Velasoft 28 Tablets combines Sofosbuvir and Velpatasvir, two direct-acting antiviral medicines that target different stages of the hepatitis C virus replication cycle. The combination is designed to suppress viral replication and help achieve sustained virologic response.

Sofosbuvir inhibits the hepatitis C virus NS5B RNA-dependent RNA polymerase, while Velpatasvir inhibits the NS5A protein, which is essential for viral replication and assembly. Together, they provide broad antiviral activity against multiple hepatitis C virus genotypes.

Velasoft is used as part of a prescribed hepatitis C treatment regimen, with the appropriate duration and monitoring determined by a qualified healthcare professional.

Product Details

Brand: Velasoft

Active Ingredients: Sofosbuvir + Velpatasvir

Dosage Form: Tablet

Pack Size: 28 tablets

Drug Class: Direct-acting antiviral

Route: Oral

Take Velasoft exactly as prescribed and complete the recommended treatment course. Tell your healthcare professional about other medicines or supplements you take, as some medicines can interact with Sofosbuvir or Velpatasvir.